Uray Iván Péter

Department of Clinical Oncology

tudományos főmunkatárs 2016-2022

Name: Uray Iván Péter

Affiliation: Debreceni Egyetem. Általános Orvostudományi Kar. Onkológiai Intézet / University of Debrecen. Faculty of Medicine. Department of Clinical Oncology

Other profiles: MTMT

Degree

MD, Debreceni Orvostudományi Egyetem (1994)
PhD, Debreceni Egyetem (2001)
Habilitáció, Debreceni Egyetem (2019)

Profession

Media links

Publication list

printer-friendly version

Export to MTMT compatible RIS file
Upload publications
Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

1995-2024

2024

Lengyel, M., Molnár, Á., Nagy, T., Jdeed, S., Garai, I., Horváth, Z., Uray, I.: Zymogen granule protein 16B (ZG16B) is a druggable epigenetic target to modulate the mammary extracellular matrix.
Cancer Sci. [Epub ahead of print]2024.

Journal metrics:

Q1 Cancer Research (2023)
D1 Medicine (miscellaneous) (2023)
Q1 Oncology (2023)

2023

Jambrovics, K., Póliska, S., Scholtz, B., Uray, I., Balajthy, Z.: ATO Increases ROS Production and Apoptosis of Cells by Enhancing Calpain-Mediated Degradation of the Cancer Survival Protein TG2.
Int. J. Mol. Sci. 24 (13), 1-11, 2023.

Journal metrics:

Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
Kola, J., Turarova, B., Csige, D., Sipos, Á., Varga, L., Gergely, B., Refai, F., Uray, I., Docsa, T., Uray, K.: Stretch-Induced Down-Regulation of HCN2 Suppresses Contractile Activity.
Molecules. 28 (11), 1-14, 2023.

Journal metrics:

Q1 Analytical Chemistry
Q1 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
Jambrovics, K., Botó, P., Pap, A., Sarang, Z., Kolostyák, Z., Czimmerer, Z., Szatmári, I., Fésüs, L., Uray, I., Balajthy, Z.: Transglutaminase 2 associated with PI3K and PTEN in a membrane-bound signalosome platform blunts cell death.
Cell Death Dis. 14 (3), 1-10, 2023.

Journal metrics:

Q1 Cancer Research
Q1 Cell Biology
Q1 Cellular and Molecular Neuroscience
Q1 Immunology
D1 Medicine (miscellaneous)

2022

Jdeed, S., Lengyel, M., Uray, I.: Redistribution of the SWI/SNF Complex Dictates Coordinated Transcriptional Control over Epithelial-Mesenchymal Transition of Normal Breast Cells through TGF-[béta] Signaling.
Cells. 11 (17), 1-15, 2022.

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Jdeed, S., Erdős, E., Bálint, B., Uray, I.: The Role of ARID1A in the Nonestrogenic Modulation of IGF-1 Signaling.
Mol. Cancer Res. 20 (7), 1071-1082, 2022.

Journal metrics:

Q1 Cancer Research
Q1 Molecular Biology
Q1 Oncology

2021

Uray, I., Uray, K.: Mechanotransduction at the Plasma Membrane-Cytoskeleton Interface.
Int. J. Mol. Sci. 22 (21), 1-23, 2021.

Journal metrics:

Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy

2020

Szivos, L., Virga, J., Hortobágyi, T., Zahuczky, G., Uray, I., Jenei, A., Bognár, L., Árkosy, P., Klekner, Á.: Az inváziós spektrum prognosztikai jelentősége glioblastomában.
Ideggyogy. Szle. 73 (9-10), 317-325, 2020.

Journal metrics:

Q4 Neurology
Q4 Neurology (clinical)
Jambrovics, K., Uray, I., Keillor, J., Fésüs, L., Balajthy, Z.: Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2.
Cancers (Basel). 12 (3), 648-, 2020.

Journal metrics:

Q2 Cancer Research
Q1 Oncology

2019

Kocsis, J., Szekanecz, É., Bassam, A., Uhlyarik, A., Pápai, Z., Rubovszky, G., Mezősi, E., Rucz, K., Garai, I., Nagy, E., Uray, I., Horváth, Z.: First Line Sorafenib Treatment for Metastatic Medullary Thyroid Cancer: efficacy and Safety Analysis.
Exp. Clin. Endocrinol. Diabetes. 127 (4), 240-246, 2019.

Journal metrics:

Q3 Endocrinology
Q3 Endocrinology, Diabetes and Metabolism
Q2 Internal Medicine
Q2 Medicine (miscellaneous)
Jambrovics, K., Uray, I., Keresztessy, Z., Keillor, J., Fésüs, L., Balajthy, Z.: Transglutaminase 2 programs differentiating acute promyelocytic leukemia cells in all-trans retinoic acid treatment to inflammatory stage through NF-kB activation.
Haematol-Hematol. J. 104 (3), 505-515, 2019.

Journal metrics:

D1 Hematology

2018

Chowdhury, P., Powell, R., Stephan, C., Uray, I., Talley, T., Karki, M., Tripathi, D., Park, Y., Mancini, M., Davies, P., Dere, R.: Bexarotene: a Novel Modulator of AURKA and the Primary Cilium in VHL-deficient Cells.
J. Cell Sci. 131 1-12, 2018.

Journal metrics:

Q1 Cell Biology

2017

Zhang, L., Shen, J., Yin, Y., Peng, Y., Wang, L., Hsieh, H., Shen, Q., Brown, P., Tao, K., Uray, I., Peng, G.: Identifying cell cycle modulators that selectively target aridia deficiency using high-throughput image-based screening.
SLAS Discovery. 1 (1), 1-14, 2017.
Zhang, L., Peng, Y., Uray, I., Shen, J., Wang, L., Peng, X., Brown, P., Tu, W., Peng, G.: Natural product [béta]-thujaplicin inhibits homologous recombination repair and sensitizes cancer cells to radiation therapy.
DNA Repair. 60 89-101, 2017.

Journal metrics:

D1 Biochemistry
Q1 Cell Biology
Q1 Molecular Biology

2016

Uray, I., Dmitrovsky, E., Brown, P.: Retinoids and Rexinoids in Cancer Prevention: From Laboratory to Clinic.
Semin. Oncol. 43 (1), 49-64, 2016.

Journal metrics:

Q1 Hematology
Q1 Oncology
Shepherd, J., Uray, I., Mazumdar, A., Tsimelzon, A., Savage, M., Hilsenbeck, S., Brown, P.: The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression.
Oncotarget. 7 (11), 1-16, 2016.

Journal metrics:

Q1 Oncology

2015

Uray, I., Rodenberg, J., Zhang, Y., Hill, J., Brown, P.: Abstract 2804: The thiazolidinedione pioglitazone enhances the cancer preventive activity of the rexinoid LG100268 in Her2/neu induced breast cancer.
Cancer Res. 75 (15), 2804, 2015.
Shen, J., Peng, Y., Wei, L., Zhang, W., Yang, L., Lan, L., Kapoor, P., Ju, Z., Mo, Q., Shih, I., Uray, I., Wu, X., Brown, P., Shen, X., Mills, G., Peng, G.: ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.
Cancer Discov. 5 (7), 752-767, 2015.

Journal metrics:

D1 Oncology

2014

Batra, N., Speers, C., Uray, I., Mazumdar, A., Tsimelzon, A., Hilsenbeck, S., Mills, G., Brown, P.: Abstract 3299: Maternal embryonic leucine zipper kinase is critical for the growth and migration of triple negative breast cancer cells.
Cancer Res. 74 (19), 3299-3299, 2014.
Xiong, A., Chen, H., Yang, Z., Cai, G., Wang, L., Ding, C., Xu, G., Wild, C., Ye, N., Uray, I., Zhou, J., Shen, Q.: Abstract 3805: Anticancer agent HJC0416 inhibits the growth of breast cancer xenografts via downregulating STAT3 signaling.
Cancer Res. 74 (19), 3805-3805, 2014.
Sárvári, A., Veréb, Z., Uray, I., Fésüs, L., Balajthy, Z.: Atypical antipsychotics induce both proinflammatory and adipogenic gene expression in human adipocytes in vitro.
Biochem. Biophys. Res. Commun. 450 (4), 1383-1389, 2014.

Journal metrics:

Q2 Biochemistry
Q1 Biophysics
Q3 Cell Biology
Q2 Molecular Biology

2012

Hartman, Z., Tsimelzon, A., Uray, I., Hill, J., Zhang, Y., Mazumdar, A., Hilsenbeck, S., Chang, J., Mills, G., Brown, P.: Abstract 4862: Autocrine secreted IL-6 and IL-8 play critical and non-redundant roles in basal-like breast cancer cell transformation and growth in vitro and in vivo.
Cancer Res. 72 (8), 4862-4862, 2012.
Wang, C., Uray, I., Mazumdar, A., Mayer, J., Brown, P.: SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE).
Breast Cancer Res. Treat. 134 (1), 101-115, 2012.

Journal metrics:

Q1 Cancer Research
Q1 Oncology

2011

Uray, I., Rodenberg, J., Bissonnette, R., Brown, P., Mancini, M.: Cancer-Preventive Rexinoid Modulates Neutral Lipid Contents of Mammary Epithelial Cells through a Peroxisome Proliferator-Activated Receptor [gamma]-Dependent Mechanism.
Molecular Pharmacology. 81 (2), 228-238, 2011.

Journal metrics:

D1 Molecular Medicine
D1 Pharmacology
Uray, I., Brown, P.: Chemoprevention of hormone receptor-negative breast cancer: new approaches needed.
Recent Results Cancer Res. 188 147-162, 2011.

Journal metrics:

Q3 Cancer Research
Q1 Medicine (miscellaneous)
Q2 Oncology

Show all

updated: 2024-12-21, 02:02

You are here

Uray Iván Péter

Uray Iván Péter

Publication list

SCImago quartiles of
scientific journal articles

SCImago subject areas and categories

Genre chart

Year chart

Language chart

Journals

iDEa co-authors

Other co-authors

You are here

Uray Iván Péter

Uray Iván Péter

Publication list

SCImago quartiles ofscientific journal articles

SCImago subject areas and categories

Genre chart

Year chart

Language chart

Journals

iDEa co-authors

Other co-authors

SCImago quartiles of
scientific journal articles